Diagnosis, Treatment and Prognosis of Cardiovascular Diseases 2.0
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (5 September 2023) | Viewed by 10305
Special Issue Editor
Interests: cardiovascular disease; cardiovascular rehabilitation; cardiology; coronary artery disease; heart failure; vascular medicine; atrial fibrillation; hypertension; cardiac imaging; cardiovascular neural control; autonomic nervous system; gender medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce the launch of a new Special Issue, “Diagnosis, Treatment and Prognosis of Cardiovascular Diseases 2.0”, a continuation of a previously successful Special Issue.
Given the success of the first edition comprising 22 high-quality articles, the second edition of the Special Issue aims to continue the publication of original articles, reviews, meta-analyses and letters related to the burden of cardiovascular diseases worldwide.
There is certainly a need for innovative and personalized strategies for the prevention, early diagnosis and optimization of medical and nonmedical therapies, along with improvements in the organizational management of chronic cardiovascular diseases. Aging and the growing number of comorbidities, increasingly accompanying heart disease, further complicating health challenges, must also be taken into account. In addition, lifestyles, in particular, smoking, a sedentary lifestyle, incorrect nutrition, sleep disorders, anxiety and depression are assuming increasing proportions, also due to the COVID-19 pandemic, ongoing wars, climate change and economic crises, which represent serious risk factors for cardiovascular diseases.
Therefore, the guidelines for diagnosis and treatment must be personalized, considering many individual variables related both to the phenotypic expression of each disease and to the genetics and epigenetics of the individual. Therefore, the role of precision medicine in cardiovascular diseases should be better defined.
This Special Issue’s second edition aims to explore these complicated and stimulating aspects by focusing on:
i) Innovative diagnostic tools;
ii) The identification of risk factors and indices of diseases and prognoses;
iii) Risk stratification and cardiovascular prevention;
iv) Drug and nondrug therapies;
v) Pathophysiology and the phenotypic expression of cardiovascular diseases;
vi) The mapping of individuals' susceptibilities to cardiovascular diseases;
ii) Cardiovascular rehabilitation;
viii) Clinical and health management models, with particular attention paid to the transfer of guideline indications into the real world.
Dr. Laura Adelaide Dalla Vecchia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular risk factors
- heart disease
- coronary syndrome
- heart failure
- dyslipidemia
- cardiovascular guidelines
- personalized treatment
- optimal medical therapy
- cardiovascular rehabilitation
- cardiovascular genetics
- cardiovascular epigenetics
- precision medicine in cardiovascular diseases
- anxiety and depression
- stressors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.